UW collaboration with Artemisia BioMedical receives $1.5M from Life Sciences Discovery Fund

University of Washington, in collaboration with Artemisia BioMedical, Inc. has won a $1.5 million award from the Life Sciences Discovery Fund to advance the development of a novel cancer-treatment technology. A UW research team under the leadership of Tomikazu Sasaki, Ph.D., will work with Artemisia BioMedical to further advance their project entitled “Development of Artemisinin Compounds for Cancer Treatment.” Artemisia BioMedical, a privately-held biotechnology company based in Newcastle, Washington, and the UW team received WTC support in 2007 for this technology which holds promise as a breakthrough for the treatment of many types of human cancer.


Press release from Artemisia BioMedical, Inc
Artemisia BioMedical, Inc. is a WTC client

This entry was posted in Artemisia_Biomedical, Funding, Life_Sciences_Discovery_Fund, UW. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s